Meanwhile, impaired autophagy of hepatic macrophages leads to the release of pro-inflammatory cytokines and chemokines (TNF-α, IL-6, and IL-1β), leading to excessive apoptosis of liver cells and activation of hepatic stellate cells, which drives the progress of NAFLD/NASH (62). The gene discussed is IL1B; the disease is metabolic dysfunction-associated steatotic liver disease.